PNPLA6 and Spastic paraplegia: Previous studies suggested that the localization of PNPLA6 variants could impact the development of different clinical phenotypes, with certain variants toward N terminal, causing preferentially ataxia and spastic paraplegia, while variants toward C terminal cause neurological symptoms with hypogonadism (26).